메뉴 건너뛰기




Volumn 21, Issue 11, 2007, Pages 1405-1414

Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase

Author keywords

Antiretroviral therapy; Antiviral drug resistance; HIV 1; K65R; Nucleoside reverse transcriptase inhibitors; Reverse transcriptase; Thymidine analog mutations

Indexed keywords

ABACAVIR; CARBOVIR; GENE PRODUCT; K65R PROTEIN; LAMIVUDINE; NUCLEOTIDE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG; ZIDOVUDINE;

EID: 34250847144     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3281ac229b     Document Type: Article
Times cited : (70)

References (43)
  • 1
    • 0034566114 scopus 로고    scopus 로고
    • Inhibitors of HIV-1 reverse transcriptase
    • Parniak MA, Sluis-Cremer N. Inhibitors of HIV-1 reverse transcriptase. Adv Pharmacol 2000; 49:67-109.
    • (2000) Adv Pharmacol , vol.49 , pp. 67-109
    • Parniak, M.A.1    Sluis-Cremer, N.2
  • 2
    • 0033770149 scopus 로고    scopus 로고
    • Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)
    • Sluis-Cremer N, Arion D, Parniak MA. Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Cell Mol Life Sci 2000; 57:1408-1422.
    • (2000) Cell Mol Life Sci , vol.57 , pp. 1408-1422
    • Sluis-Cremer, N.1    Arion, D.2    Parniak, M.A.3
  • 3
    • 0038369038 scopus 로고    scopus 로고
    • Nucleotide analogue binding, catalysis and primer unblocking in the mechanisms of HIV-1 reverse transcriptase-mediated resistance to nucleoside analogues
    • Selmi B, Deval J, Boretto J, Canard B. Nucleotide analogue binding, catalysis and primer unblocking in the mechanisms of HIV-1 reverse transcriptase-mediated resistance to nucleoside analogues. Antivir Ther 2003; 8:143-154.
    • (2003) Antivir Ther , vol.8 , pp. 143-154
    • Selmi, B.1    Deval, J.2    Boretto, J.3    Canard, B.4
  • 4
    • 3242879168 scopus 로고    scopus 로고
    • Structural determinants and molecular mechanisms for the resistance of HIV-1 RT to nucleoside analogues
    • Deval J, Courcambeck J, Selmi B, Boretto J, Canard B. Structural determinants and molecular mechanisms for the resistance of HIV-1 RT to nucleoside analogues. Curr Drug Metab 2004; 5:305-316.
    • (2004) Curr Drug Metab , vol.5 , pp. 305-316
    • Deval, J.1    Courcambeck, J.2    Selmi, B.3    Boretto, J.4    Canard, B.5
  • 5
    • 0032506055 scopus 로고    scopus 로고
    • Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase
    • Arion D, Kaushik N, McCormick S, Borkow G, Parniak MA. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 1998; 37:15908-15917.
    • (1998) Biochemistry , vol.37 , pp. 15908-15917
    • Arion, D.1    Kaushik, N.2    McCormick, S.3    Borkow, G.4    Parniak, M.A.5
  • 6
    • 0033165851 scopus 로고    scopus 로고
    • A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase
    • Meyer PR, Matsuura SE, Mian AM, So AG, Scott WA. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol Cell 1999; 4:35-43.
    • (1999) Mol Cell , vol.4 , pp. 35-43
    • Meyer, P.R.1    Matsuura, S.E.2    Mian, A.M.3    So, A.G.4    Scott, W.A.5
  • 7
    • 0035031936 scopus 로고    scopus 로고
    • Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase
    • Boyer PL, Sarafianos SG, Arnold E, Hughes SH. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J Virol 2001; 75:4832-4842.
    • (2001) J Virol , vol.75 , pp. 4832-4842
    • Boyer, P.L.1    Sarafianos, S.G.2    Arnold, E.3    Hughes, S.H.4
  • 8
    • 0033587620 scopus 로고    scopus 로고
    • Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase
    • Feng JY, Anderson KS. Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase. Biochemistry 1999; 38:9440-9448.
    • (1999) Biochemistry , vol.38 , pp. 9440-9448
    • Feng, J.Y.1    Anderson, K.S.2
  • 9
    • 0035930584 scopus 로고    scopus 로고
    • Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue
    • Selmi B, Boretto J, Sarfati SR, Guerreiro C, Canard B. Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue. J Biol Chem 2001; 276:48466-48472.
    • (2001) J Biol Chem , vol.276 , pp. 48466-48472
    • Selmi, B.1    Boretto, J.2    Sarfati, S.R.3    Guerreiro, C.4    Canard, B.5
  • 10
    • 0036829992 scopus 로고    scopus 로고
    • The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues
    • Deval J, Selmi B, Boretto J, Egloff MP, Guerreiro C, Sarfati S, Canard B. The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues. J Biol Chem 2002; 277:42097-42104.
    • (2002) J Biol Chem , vol.277 , pp. 42097-42104
    • Deval, J.1    Selmi, B.2    Boretto, J.3    Egloff, M.P.4    Guerreiro, C.5    Sarfati, S.6    Canard, B.7
  • 11
    • 0347052875 scopus 로고    scopus 로고
    • Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
    • Deval J, White KL, Miller MD, Parkin NT, Courcambeck J, Halfon P, et al. Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations. J Biol Chem 2004; 279:509-516.
    • (2004) J Biol Chem , vol.279 , pp. 509-516
    • Deval, J.1    White, K.L.2    Miller, M.D.3    Parkin, N.T.4    Courcambeck, J.5    Halfon, P.6
  • 12
    • 2942616457 scopus 로고    scopus 로고
    • A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions
    • Deval J, Navarro JM, Selmi B, Courcambeck J, Boretto J, Halfon P, et al. A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions. J Biol Chem 2004; 279:25489-25496.
    • (2004) J Biol Chem , vol.279 , pp. 25489-25496
    • Deval, J.1    Navarro, J.M.2    Selmi, B.3    Courcambeck, J.4    Boretto, J.5    Halfon, P.6
  • 13
    • 0034947293 scopus 로고    scopus 로고
    • Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: Analysis of enzyme processivity, chain-terminator removal and viral replication
    • Naeger LK, Margot NA, Miller MD. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication. Antivir Ther 2001; 6:115-126.
    • (2001) Antivir Ther , vol.6 , pp. 115-126
    • Naeger, L.K.1    Margot, N.A.2    Miller, M.D.3
  • 14
    • 0036124432 scopus 로고    scopus 로고
    • The M184V mutation reduces the selective excision of zidovudine 5′-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1
    • Boyer PL, Sarafianos SG, Arnold E, Hughes SH. The M184V mutation reduces the selective excision of zidovudine 5′-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1. J Virol 2002; 76:3248-3256.
    • (2002) J Virol , vol.76 , pp. 3248-3256
    • Boyer, P.L.1    Sarafianos, S.G.2    Arnold, E.3    Hughes, S.H.4
  • 15
    • 21444452131 scopus 로고    scopus 로고
    • The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations
    • Miranda LR, Gotte M, Liang F, Kuritzkes DR. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations. Antimicrob Agents Chemother 2005; 49:2648-2656.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 2648-2656
    • Miranda, L.R.1    Gotte, M.2    Liang, F.3    Kuritzkes, D.R.4
  • 16
    • 33645500469 scopus 로고    scopus 로고
    • The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations
    • White KL, Chen JM, Feng JY, Margot NA, Ly JK, Ray AS, et al. The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations. Antivir Ther 2006; 11:155-163.
    • (2006) Antivir Ther , vol.11 , pp. 155-163
    • White, K.L.1    Chen, J.M.2    Feng, J.Y.3    Margot, N.A.4    Ly, J.K.5    Ray, A.S.6
  • 17
    • 0029028067 scopus 로고
    • Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
    • Larder BA, Kemp SD, Harrigan PR. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 1995; 269:696-699.
    • (1995) Science , vol.269 , pp. 696-699
    • Larder, B.A.1    Kemp, S.D.2    Harrigan, P.R.3
  • 18
    • 0028273314 scopus 로고
    • Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations
    • Shafer RW, Kozal MJ, Winters MA, Iversen AK, Katzenstein DA, Ragni MV, et al. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J Infect Dis 1994; 169:722-729.
    • (1994) J Infect Dis , vol.169 , pp. 722-729
    • Shafer, R.W.1    Kozal, M.J.2    Winters, M.A.3    Iversen, A.K.4    Katzenstein, D.A.5    Ragni, M.V.6
  • 19
    • 0036897074 scopus 로고    scopus 로고
    • Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine
    • Stoeckli TC, MaWhinney S, Uy J, Duan C, Lu J, Shugarts D, Kuritzkes DR. Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine. Antimicrob Agents Chemother 2002; 46:4000-4003.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 4000-4003
    • Stoeckli, T.C.1    MaWhinney, S.2    Uy, J.3    Duan, C.4    Lu, J.5    Shugarts, D.6    Kuritzkes, D.R.7
  • 20
    • 14744267571 scopus 로고    scopus 로고
    • In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase
    • Parikh UM, Koontz DL, Chu CK, Schinazi RF, Mellors JW. In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. Antimicrob Agents Chemother 2005; 49:1139-1144.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 1139-1144
    • Parikh, U.M.1    Koontz, D.L.2    Chu, C.K.3    Schinazi, R.F.4    Mellors, J.W.5
  • 21
    • 0037131342 scopus 로고    scopus 로고
    • The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients
    • Winston A, Mandalia S, Pillay D, Gazzard B, Pozniak A. The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients. AIDS 2002; 16:2087-2089.
    • (2002) AIDS , vol.16 , pp. 2087-2089
    • Winston, A.1    Mandalia, S.2    Pillay, D.3    Gazzard, B.4    Pozniak, A.5
  • 22
    • 33646440592 scopus 로고    scopus 로고
    • The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations
    • Parikh UM, Bacheler L, Koontz D, Mellors JW. The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations. J Virol 2006; 80:4971-4977.
    • (2006) J Virol , vol.80 , pp. 4971-4977
    • Parikh, U.M.1    Bacheler, L.2    Koontz, D.3    Mellors, J.W.4
  • 23
    • 2342661255 scopus 로고    scopus 로고
    • K65R, TAMs and tenofovir
    • Miller MD. K65R, TAMs and tenofovir. AIDS Rev 2004; 6:22-33.
    • (2004) AIDS Rev , vol.6 , pp. 22-33
    • Miller, M.D.1
  • 24
    • 7744219542 scopus 로고    scopus 로고
    • Predictors of selection of K65R: Tenofovir use and lack of thymidine analogue mutations
    • Valer L, Martin-Carbonero L, deMendoza C, Corral A, Soriano V. Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations. AIDS 2004; 18:2094-2096.
    • (2004) AIDS , vol.18 , pp. 2094-2096
    • Valer, L.1    Martin-Carbonero, L.2    deMendoza, C.3    Corral, A.4    Soriano, V.5
  • 25
    • 11844255339 scopus 로고    scopus 로고
    • Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1
    • Segondy M, Montes B. Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1. J Acquir Immune Defic Syndr 2005; 38:110-111.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 110-111
    • Segondy, M.1    Montes, B.2
  • 26
    • 20044390947 scopus 로고    scopus 로고
    • Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients
    • Wirden M, Marcelin AG, Simon A, Kirstetter M, Tubiana R, Valantin MA, et al. Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients. J Med Virol 2005; 76:297-301.
    • (2005) J Med Virol , vol.76 , pp. 297-301
    • Wirden, M.1    Marcelin, A.G.2    Simon, A.3    Kirstetter, M.4    Tubiana, R.5    Valantin, M.A.6
  • 27
    • 33748052358 scopus 로고    scopus 로고
    • Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level
    • Parikh UM, Barnas DC, Faruki H, Mellors JW. Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level. J Infect Dis 2006; 194:651-660.
    • (2006) J Infect Dis , vol.194 , pp. 651-660
    • Parikh, U.M.1    Barnas, D.C.2    Faruki, H.3    Mellors, J.W.4
  • 28
    • 0025191211 scopus 로고
    • Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography
    • Le Grice SF, Gruninger-Leitch F. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem 1990; 187:307-314.
    • (1990) Eur J Biochem , vol.187 , pp. 307-314
    • Le Grice, S.F.1    Gruninger-Leitch, F.2
  • 29
    • 0028789990 scopus 로고
    • Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase
    • Le Grice SF, Cameron CE, Benkovic SJ. Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol 1995; 262:130-144.
    • (1995) Methods Enzymol , vol.262 , pp. 130-144
    • Le Grice, S.F.1    Cameron, C.E.2    Benkovic, S.J.3
  • 31
    • 23844479950 scopus 로고    scopus 로고
    • The 3′-azido group is not the primary determinant of 3′-azido-3′-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1
    • Sluis-Cremer N, Arion D, Parikh U, Koontz D, Schinazi RF, Mellors JW, Parniak MA. The 3′-azido group is not the primary determinant of 3′-azido-3′-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1. J Biol Chem 2005; 280:29047-29052.
    • (2005) J Biol Chem , vol.280 , pp. 29047-29052
    • Sluis-Cremer, N.1    Arion, D.2    Parikh, U.3    Koontz, D.4    Schinazi, R.F.5    Mellors, J.W.6    Parniak, M.A.7
  • 32
    • 0034737638 scopus 로고    scopus 로고
    • Mechanism by which phosphonoformic acid resistance mutations restore 3′-azido-3′- deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase
    • Arion D, Sluis-Cremer N, Parniak MA. Mechanism by which phosphonoformic acid resistance mutations restore 3′-azido-3′- deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase. J Biol Chem 2000; 275:9251-9255.
    • (2000) J Biol Chem , vol.275 , pp. 9251-9255
    • Arion, D.1    Sluis-Cremer, N.2    Parniak, M.A.3
  • 33
    • 22244458608 scopus 로고    scopus 로고
    • Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5(-O-1-thiotriphosphate
    • E-pub 3 June
    • Radzio J, Sluis-Cremer N. Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5(-O-1-thiotriphosphate. Protein Sci 2005; 14:1929-1933; E-pub 3 June 2005.
    • (2005) Protein Sci 2005 , vol.14 , pp. 1929-1933
    • Radzio, J.1    Sluis-Cremer, N.2
  • 34
    • 0028916224 scopus 로고
    • Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates
    • Johnson KA. Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates. Methods Enzymol 1995; 249:38-61.
    • (1995) Methods Enzymol , vol.249 , pp. 38-61
    • Johnson, K.A.1
  • 35
    • 0142042463 scopus 로고    scopus 로고
    • Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates
    • Whitcomb JM, Parkin NT, Chappey C, Hellmann NS, Petropoulos CJ. Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates. J Infect Dis 2003; 188:992-1000.
    • (2003) J Infect Dis , vol.188 , pp. 992-1000
    • Whitcomb, J.M.1    Parkin, N.T.2    Chappey, C.3    Hellmann, N.S.4    Petropoulos, C.J.5
  • 36
    • 27544431950 scopus 로고    scopus 로고
    • A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT
    • White KL, Margot NA, Ly JK, Chen JM, Ray AS, Pavelko M, et al. A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT. AIDS 2005; 19:1751-1760.
    • (2005) AIDS , vol.19 , pp. 1751-1760
    • White, K.L.1    Margot, N.A.2    Ly, J.K.3    Chen, J.M.4    Ray, A.S.5    Pavelko, M.6
  • 37
    • 0042347690 scopus 로고    scopus 로고
    • Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis
    • Ray AS, Murakami E, Basavapathruni A, Vaccaro JA, Ulrich D, Chu CK, et al. Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis. Biochemistry 2003; 42:8831-8841.
    • (2003) Biochemistry , vol.42 , pp. 8831-8841
    • Ray, A.S.1    Murakami, E.2    Basavapathruni, A.3    Vaccaro, J.A.4    Ulrich, D.5    Chu, C.K.6
  • 38
    • 0142100752 scopus 로고    scopus 로고
    • The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis
    • Gotte M, Arion D, Parniak MA, Wainberg MA. The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis. J Virol 2000; 74:3579-3585.
    • (2000) J Virol , vol.74 , pp. 3579-3585
    • Gotte, M.1    Arion, D.2    Parniak, M.A.3    Wainberg, M.A.4
  • 39
    • 21444443785 scopus 로고    scopus 로고
    • Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase
    • Frankel FA, Marchand B, Turner D, Gotte M, Wainberg MA. Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 2005; 49:2657-2664.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 2657-2664
    • Frankel, F.A.1    Marchand, B.2    Turner, D.3    Gotte, M.4    Wainberg, M.A.5
  • 40
    • 2342453265 scopus 로고    scopus 로고
    • Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
    • Tuske S, Sarafianos SG, Clark AD Jr, Ding J, Naeger LK, White KL, et al. Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol 2004; 11:469-474.
    • (2004) Nat Struct Mol Biol , vol.11 , pp. 469-474
    • Tuske, S.1    Sarafianos, S.G.2    Clark Jr, A.D.3    Ding, J.4    Naeger, L.K.5    White, K.L.6
  • 41
    • 0032573488 scopus 로고    scopus 로고
    • Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance
    • Huang H, Chopra R, Verdine GL, Harrison SC. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 1998; 282:1669-1675.
    • (1998) Science , vol.282 , pp. 1669-1675
    • Huang, H.1    Chopra, R.2    Verdine, G.L.3    Harrison, S.C.4
  • 43
    • 0031925680 scopus 로고    scopus 로고
    • A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2′,3′-dideoxy-3′-thiacytidine
    • Kemp SD, Shi C, Bloor S, Harrigan PR, Mellors JW, Larder BA. A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2′,3′-dideoxy-3′-thiacytidine. J Virol 1998; 72:5093-5098.
    • (1998) J Virol , vol.72 , pp. 5093-5098
    • Kemp, S.D.1    Shi, C.2    Bloor, S.3    Harrigan, P.R.4    Mellors, J.W.5    Larder, B.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.